Improved Cerebral Energetics and Ketone Body Metabolism in Db/db Mice
Overview
Endocrinology
Neurology
Affiliations
It is becoming evident that type 2 diabetes mellitus is affecting brain energy metabolism. The importance of alternative substrates for the brain in type 2 diabetes mellitus is poorly understood. The aim of this study was to investigate whether ketone bodies are relevant candidates to compensate for cerebral glucose hypometabolism and unravel the functionality of cerebral mitochondria in type 2 diabetes mellitus. Acutely isolated cerebral cortical and hippocampal slices of db/db mice were incubated in media containing [U-C]glucose, [1,2-C]acetate or [U-C]β-hydroxybutyrate and tissue extracts were analysed by mass spectrometry. Oxygen consumption and ATP synthesis of brain mitochondria of db/db mice were assessed by Seahorse XFe96 and luciferin-luciferase assay, respectively. Glucose hypometabolism was observed for both cerebral cortical and hippocampal slices of db/db mice. Significant increased metabolism of [1,2-C]acetate and [U-C]β-hydroxybutyrate was observed for hippocampal slices of db/db mice. Furthermore, brain mitochondria of db/db mice exhibited elevated oxygen consumption and ATP synthesis rate. This study provides evidence of several changes in brain energy metabolism in type 2 diabetes mellitus. The increased hippocampal ketone body utilization and improved mitochondrial function in db/db mice, may act as adaptive mechanisms in order to maintain cerebral energetics during hampered glucose metabolism.
The Glutamate/GABA-Glutamine Cycle: Insights, Updates, and Advances.
Andersen J J Neurochem. 2025; 169(3):e70029.
PMID: 40066661 PMC: 11894596. DOI: 10.1111/jnc.70029.
Alterations of the glutamatergic system in diabetes mellitus.
Hristov M, Nankova A, Andreeva-Gateva P Metab Brain Dis. 2023; 39(2):321-333.
PMID: 37747631 DOI: 10.1007/s11011-023-01299-z.
The gut microbiota-astrocyte axis: Implications for type 2 diabetic cognitive dysfunction.
Li Z, Jiang Y, Long C, Peng Q, Yue R CNS Neurosci Ther. 2023; 29 Suppl 1:59-73.
PMID: 36601656 PMC: 10314112. DOI: 10.1111/cns.14077.
Ameen A, Freude K, Aldana B Biomedicines. 2022; 10(11).
PMID: 36359298 PMC: 9687972. DOI: 10.3390/biomedicines10112778.
Westi E, Jakobsen E, Voss C, Bak L, Pinborg L, Aldana B Mol Neurobiol. 2022; 59(12):7495-7512.
PMID: 36201140 DOI: 10.1007/s12035-022-03053-5.